88 related articles for article (PubMed ID: 10464578)
1. Understanding probabilistic risk in predisposition genetic testing for Alzheimer disease.
Koenig BA; Silverberg HL
Genet Test; 1999; 3(1):55-63. PubMed ID: 10464578
[TBL] [Abstract][Full Text] [Related]
2. A philosophical critique of decision analysis as a tool in genetic testing.
Kaplan JM
Genet Test; 1999; 3(1):85-91. PubMed ID: 10464581
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.
McConnell LM; Koenig BA; Greely HT; Raffin TA
Genet Test; 1999; 3(1):3-12. PubMed ID: 10464572
[TBL] [Abstract][Full Text] [Related]
4. The application of medical decision analysis to genetic testing: an introduction.
McConnell LM; Goldstein MK
Genet Test; 1999; 3(1):65-70. PubMed ID: 10464579
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
6. The genetics of Alzheimer disease and the application of molecular tests.
Tobin SL; Chun N; Powell TM; McConnell LM
Genet Test; 1999; 3(1):37-45. PubMed ID: 10464576
[TBL] [Abstract][Full Text] [Related]
7. The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?
Arribas-Ayllon M
Br Med Bull; 2011; 100():7-21. PubMed ID: 21672937
[TBL] [Abstract][Full Text] [Related]
8. Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective.
Post SG
Am J Prev Med; 1999 Feb; 16(2):105-10. PubMed ID: 10343886
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.
Gooding HC; Linnenbringer EL; Burack J; Roberts JS; Green RC; Biesecker BB
Patient Educ Couns; 2006 Dec; 64(1-3):259-67. PubMed ID: 16860524
[TBL] [Abstract][Full Text] [Related]
10. Advances in genetic testing for Alzheimer's disease.
Howard KL; Filley CM
Rev Neurol Dis; 2009; 6(1):26-32. PubMed ID: 19367221
[TBL] [Abstract][Full Text] [Related]
11. The psychological impact of genetic testing for Alzheimer disease.
Coon DW; Davies H; McKibben C; Gallagher-Thompson D
Genet Test; 1999; 3(1):121-31. PubMed ID: 10464586
[TBL] [Abstract][Full Text] [Related]
12. Special issues in genetic testing for Alzheimer disease.
Greely HT
Genet Test; 1999; 3(1):115-9. PubMed ID: 10464585
[TBL] [Abstract][Full Text] [Related]
13. Perspectives in genetic prediction of Alzheimer's disease.
Šerý O; Povová J; Balcar VJ
Neuro Endocrinol Lett; 2014; 35(5):359-66. PubMed ID: 25275266
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing, Alzheimer disease, and long-term care insurance.
Fogarty M
Genet Test; 1999; 3(1):133-7. PubMed ID: 10464587
[TBL] [Abstract][Full Text] [Related]
15. Ethical issues in genetic testing for Alzheimer's disease.
Kahn J
Geriatrics; 1997 Sep; 52 Suppl 2():S30-2. PubMed ID: 9307583
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease.
van der Cammen TJ; Croes EA; Dermaut B; de Jager MC; Cruts M; Van Broeckhoven C; van Duijn CM
J Am Geriatr Soc; 2004 Dec; 52(12):2110-3. PubMed ID: 15571552
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility genes and the question of embodied identity.
Lock M; Freeman J; Chilibeck G; Beveridge B; Padolsky M
Med Anthropol Q; 2007 Sep; 21(3):256-76. PubMed ID: 17937249
[TBL] [Abstract][Full Text] [Related]
18. Decision analysis and Alzheimer disease: three case studies.
Holtzman S; Ozanne E; Carone B; Goldstein MK; Steinke G; Timbs J
Genet Test; 1999; 3(1):71-83. PubMed ID: 10464580
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing and Alzheimer's disease: implications for psychiatric-mental health nursing.
Schutte DL
J Psychosoc Nurs Ment Health Serv; 2013 Nov; 51(11):14-8. PubMed ID: 24124693
[TBL] [Abstract][Full Text] [Related]
20. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
